Novo Nordisk’s Next Hurdle: August Earnings Will Test Whether Pill Uptake Can Counter a 65% Canadi
Novo Nordisk shares rebound 10% but remain down 15% YTD. Generic Ozempic competition looms in Canada, while oral…
Novo Nordisk’s Wegovy® Pill Achieves Strong First-Month Uptake, Signaling Expanding Demand for Oral GLP-1s in Obesity
Awareness and prescribing of the Wegovy pill for weight loss surge among primary care physicians and endocrinologists following…